Zhao Long Gong
Chief Executive Officer bij 3D MEDICINES INC.
Vermogen: 28 M $ op 31-03-2024
Profiel
Zhao Long Gong is the Chairman & Chief Executive Officer and founder of 3D Medicines, Inc. which is founded in 2014.
He is currently an Independent Director at Shanghai Innostar Biotechnology Co., Ltd.
since 2021.
Dr. Gong was previously an Independent Director at Shandong Jincheng Pharmaceutical Group Co., Ltd.
and Staidson (Beijing) Biopharmaceuticals Co., Ltd.
from 2015 to 2021.
Dr. Gong received his doctorate degree from New York University in 1996 and his undergraduate and graduate degrees from Peking University Health Science Center.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
3D MEDICINES, INC.
13.94% | 05-04-2024 | 35 992 364 ( 13.94% ) | 28 M $ | 31-03-2024 |
Actieve functies van Zhao Long Gong
Bedrijven | Functie | Begin |
---|---|---|
3D MEDICINES INC. | Chief Executive Officer | 01-01-2014 |
Shanghai Innostar Biotechnology Co., Ltd.
Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Director/Board Member | 13-08-2021 |
Eerdere bekende functies van Zhao Long Gong
Bedrijven | Functie | Einde |
---|---|---|
SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD | Director/Board Member | 12-05-2023 |
STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD. | Director/Board Member | 11-08-2021 |
Opleiding van Zhao Long Gong
New York University | Doctorate Degree |
Peking University Health Science Center | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD | Health Technology |
STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD. | Health Technology |
3D MEDICINES INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Shanghai Innostar Biotechnology Co., Ltd.
Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Commercial Services |